Browsing Category
Pharma Industry News
4741 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Travere Therapeutics stock soars 25% as FDA skips advisory panel for FSGS drug FILSPARI
Travere stock jumped 25% after the FDA waived an advisory panel for its FSGS drug. Find out why FILSPARI could transform the rare kidney disease market.
Base editing vs CRISPR: Why Beam Therapeutics’ sickle cell therapy may quietly become a blockbuster
Weeks after Beam’s BEAM-101 earned RMAT status, here’s why base editing may still reshape sickle cell therapy—and what investors should watch next.
How recombinant therapies are reshaping bleeding disorder treatment for children in 2025
Recombinant therapies are replacing plasma-derived treatments for pediatric bleeding disorders—see what’s driving this shift in 2025 and who’s leading.
Will NASP transform gout care in 2026? Sobi’s biologic therapy heads for FDA decision
Sobi’s NASP for uncontrolled gout advances to FDA review with June 2026 PDUFA date. Find out how this novel therapy could reshape gout treatment.
KRTL Holding merges with Bolivia’s Sigma Pharma to expand cross-border biotech operations
KRTL merges with Bolivia’s Sigma to build a cross-border pharma powerhouse. Find out what this means for U.S. biotech expansion in Latin America.
Why is Novartis acquiring Tourmaline Bio—and how does pacibekitug fit into its cardiovascular pipeline?
Novartis is acquiring Tourmaline Bio in a $1.4B deal to advance pacibekitug, a promising anti-IL-6 therapy for atherosclerotic cardiovascular disease.
Doceree launches RepTwin, an AI-powered solution to transform healthcare professional engagement at Fierce Pharma Week 2025
Doceree launches RepTwin at Fierce Pharma Week 2025, introducing an AI-powered virtual rep to transform pharmaceutical engagement with healthcare providers.
PhotonPharma secures U.S. patent for cancer immunotherapy technology with potential to reshape ovarian cancer treatment
PhotonPharma secures U.S. patent for Innocell cancer vaccine tech, targeting ovarian cancer with scalable immunotherapy. See how it could reshape oncology.
Amgen and Kyowa Kirin report Phase 3 rocatinlimab results highlighting long-term safety and durable response in atopic dermatitis
Amgen and Kyowa Kirin report Phase 3 rocatinlimab results showing long-term safety and durable efficacy in atopic dermatitis. Find out what comes next.
Is Ocular Therapeutix the next big biotech buyout? Takeover rumors spark investor frenzy
Ocular Therapeutix stock jumps on takeover rumors. Find out what analysts are saying, and why Axpaxl could make it biotech’s next big M&A target.